EUVIMEDEUVIMED entdecken
Open Access

SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein

Andrew D Chesney iD, Buddhadev Maiti iD, Ulrich H E Hansmann iD

The Journal of Chemical Physics · 2023

DOI: 10.1063/5.0157331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Chemical Physics, 2023. Verfasst von Andrew D Chesney und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, Division of Molecular and Cellular Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is accompanied by the presence of amyloids in the brain that are formed of α-synuclein chains. The correlation between COVID-19 and the onset of Parkinson’s disease led to the idea that amyloidogenic segments in SARS-COV-2 proteins can induce aggregation of α-synuclein. Using molecular dynamic simulations, we show that the fragment FKNIDGYFKI of the spike protein, which is unique for SARS-COV-2, preferentially shifts the ensemble of α-synuclein monomer toward rod-like fibril seeding conformations and, at the same time, differentially stabilizes this polymorph over the competing twister-like structure. Our results are compared with earlier work relying on a different protein fragment that is not specific for SARS-COV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseSpike Glycoprotein, CoronavirusHumansAmyloidSARS-CoV-2

Substanzen

alpha-SynucleinAmyloidSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, USA.

ORCID-Profile: Andrew D Chesney, Buddhadev Maiti, Ulrich H E Hansmann

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • Division of Molecular and Cellular Biosciences

Zitieren

APA

Chesney, A. D., Maiti, B., & Hansmann, U. H. E. (2023). SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein. The Journal of Chemical Physics. https://doi.org/10.1063/5.0157331

Vancouver

Chesney AD, Maiti B, Hansmann UHE. SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein. The Journal of Chemical Physics. 2023. doi:10.1063/5.0157331

BibTeX
@article{Chesney2023,
  author = {Chesney, Andrew D and Maiti, Buddhadev and Hansmann, Ulrich H E},
  title = {SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein},
  journal = {The Journal of Chemical Physics},
  year = {2023},
  doi = {10.1063/5.0157331}
}
Kostenlos starten →